Current management of onychomycosis. An overview

Dermatologic Clinics
A K GuptaP De Doncker

Abstract

Until recently pedal onychomycosis, particularly when it affected several nails or involved a large nail plate area, was often regarded as untreatable. The advent of new therapies such as itraconazole, terbinafine, and fluconazole has been a significant and welcome addition to the armamentarium of therapies at the disposal of the physician. These drugs appear in the nail plate within days of starting oral therapy, being taken up by both the nail matrix and the nail bed. The duration required for effective therapy has been reduced, while the efficacy rates and cost-effectiveness have increased compared with the older treatments, such as griseofulvin. Some of the newer agents appear to have a wider spectrum of activity. Thus far, the newer agent have exhibited a low risk to benefit ratio. I may be possible to combine oral therapies with topical and surgical treatments, thereby further increasing efficacy rates and the cost-effectiveness while decreasing adverse effects and duration of oral therapy.

References

Mar 1, 1977·Archives of Dermatology·F K Bagatell
Apr 1, 1979·Antimicrobial Agents and Chemotherapy·S JevonsM R Leeming
May 1, 1992·Journal of the American Academy of Dermatology·M WillemsenD Roseeuw
Feb 1, 1992·The Journal of Antimicrobial Chemotherapy·T PiepponenK Turjanmaa
Apr 25, 1992·Lancet·S Shuster, C S Munro
Sep 1, 1992·Clinical and Experimental Dermatology·R J Hay
Sep 1, 1992·Clinical and Experimental Dermatology·J Lauharanta
Sep 1, 1992·Clinical and Experimental Dermatology·M Zaug, M Bergstraesser
Feb 1, 1992·The British Journal of Dermatology·J G van der SchroeffJ Wuite
Feb 1, 1992·The British Journal of Dermatology·F Baudraz-RosseletR Kenzelmann
Feb 1, 1992·The British Journal of Dermatology·N S Ryder
Feb 1, 1992·The British Journal of Dermatology·V V Villars, T C Jones
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R Graybill
Oct 1, 1991·Clinics in Dermatology·B B AbramsT Hoehler
Jan 1, 1991·Journal of the American Podiatric Medical Association·D F Hettinger, M S Valinsky
Jul 1, 1991·The British Journal of Dermatology·M JohnsonS Shuster
Jan 1, 1991·Skin Pharmacology : the Official Journal of the Skin Pharmacology Society·C G Ceschin-RoquesG Michel
Nov 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H J SchmittD Armstrong
Apr 1, 1990·International Journal of Dermatology·D DompmartinJ P Coulaud
Oct 1, 1990·Journal of the American Academy of Dermatology·N Zaias
Oct 1, 1990·Journal of the American Academy of Dermatology·R K Scher, J M Barnett
Oct 1, 1990·Journal of the American Academy of Dermatology·J E Birnbaum
May 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G S Kobayashi, E D Spitzer
Mar 1, 1989·Clinical and Experimental Dermatology·Y M Clayton
Feb 1, 1988·Journal of the American Academy of Dermatology·G CauwenberghK Haeverans
Sep 1, 1988·The British Journal of Dermatology·R J HayG Midgely
Sep 1, 1985·Clinical and Experimental Dermatology·R Baran, R J Hay
May 1, 1988·Clinical and Experimental Dermatology·R J HayG Midgley
Mar 1, 1985·Clinical and Experimental Dermatology·R J HayY M Clayton
Jan 1, 1988·Annals of the New York Academy of Sciences·A Stütz
Dec 1, 1987·Antimicrobial Agents and Chemotherapy·J N Galgiani
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·G PetranyiH Mieth
Sep 1, 1987·Antimicrobial Agents and Chemotherapy·G PetranyiH Mieth
Apr 1, 1972·Archives of Dermatology·N DabrowaV D Newcomer
Jul 1, 1984·Antimicrobial Agents and Chemotherapy·A Espinel-IngroffR J Gebhart

❮ Previous
Next ❯

Citations

Dec 20, 2002·Clinics in Dermatology·Joseph Obadiah, Richard Scher
Oct 9, 1999·International Journal of Dermatology·A K Gupta, J Lambert
Aug 12, 2000·International Journal of Dermatology·A K GuptaH Degreef
Mar 30, 2001·International Journal of Dermatology·S Jain, V N Sehgal
Dec 5, 1998·The Australasian Journal of Dermatology·A K Gupta, C R Daniel
Jul 6, 2010·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Ursula BechertTodd Schmitt
Aug 12, 2000·Drugs & Aging·A K Gupta
Jul 28, 2001·Clinical Pharmacokinetics·D Debruyne, A Coquerel
Feb 24, 2001·Drugs·J F Meis, P E Verweij
Dec 29, 1998·International Journal of Dermatology·A K GuptaP Rich
Jan 15, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·R Baran, A Kaoukhov
Jun 13, 2006·The Journal of Dermatological Treatment·Shemer AvnerTrau Henri
Jun 7, 2005·Expert Opinion on Pharmacotherapy·Robert BaranGerald E Piérard
Sep 6, 2003·Dermatologic Clinics·Aditya K Gupta, Jennifer E Ryder
Jan 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A K Gupta, N H Shear
Jun 24, 2008·The Journal of Dermatological Treatment·Robert BaranJavier I Garduno
May 29, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·A K GuptaA Tavakkol
May 20, 2008·Journal of the American Podiatric Medical Association·Aditya K GuptaJagpal Singh
May 17, 2002·Journal of the American Podiatric Medical Association·Aditya K Gupta
Dec 17, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·A K GuptaR Summerbell
Apr 17, 2001·PharmacoEconomics·D M StierJ Broering
May 25, 2010·Mycoses·Silvia MenéndezYordana Maqueira
Jun 7, 2013·Therapeutic Delivery·S Narasimha Murthy
Jan 24, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joong Sup ShimJun O Liu
Apr 16, 2003·International Journal of Dermatology·Aditya K GuptaRichard C Summerbell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the European Academy of Dermatology and Venereology : JEADV
A K Gupta, N H Shear
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
A K Gupta, N H Shear
Dermatology : International Journal for Clinical and Investigative Dermatology
E HanekeA Heremans
Journal of the American Academy of Dermatology
J AndréM Ledoux
© 2022 Meta ULC. All rights reserved